Outcomes of Treatment for Melanoma Brain Metastases

Table 1

Clinicopathological characteristics of the patients.

Characteristics	Number of patients
Gender
Women	27 (54%)
Men	23 (46%)
Age
<30	2 (4%)
30–50	19 (38%)
51–70	21 (42%)
>71	8 (16%)
BRAF mutation
Unknown	35 (70%)
(+)	8 (16%)
(-)	7 (14%)
Number of brain metastases
1	13 (26%)
>1	37 (74%)
Surgery (brain metastases)
(+)	15 (30%)
(-)	35 (70%)
Radiotherapy
(+)	35 (70%)
(-)	15 (30%)
Primary melanoma localisation:
-Cutaneous	43 (86%)
-Uveal	1 (2%)
-Unknown primary	6 (12%)
Systemic therapy (after a diagnosis of brain metastases)
(+)	16 (32%)
(-)	34 (68%)